Metabolomics Workbench : NIH Data Repository

Clustering data with heatmap algorithm for (Study ST003657)

This analysis uses the 'heatmap.2' function of gplots package in the R statistics environment

The rows are scaled to have mean=0 and standard deviation=1

Factors:

F1	Sample source:U251 \| Condition:anti-GLS1 siRNA \| Method of exposure:Transfection
F2	Sample source:U251 \| Condition:Control \| Method of exposure:Direct exposure
F3	Sample source:U251 \| Condition:Control \| Method of exposure:Transfection
F4	Sample source:U251 \| Condition:Control \| Method of exposure:Transwell b.End3
F5	Sample source:U251 \| Condition:Control \| Method of exposure:Transwell b.End3 + iNHA
F6	Sample source:U251 \| Condition:Lipofectamine \| Method of exposure:Transfection
F7	Sample source:U251 \| Condition:PUREG4-LA12-anti-GLS1 siRNA \| Method of exposure:Direct exposure
F8	Sample source:U251 \| Condition:PUREG4-LA12-anti-GLS1 siRNA \| Method of exposure:Transwell b.End3
F9	Sample source:U251 \| Condition:PUREG4-LA12-anti-GLS1 siRNA \| Method of exposure:Transwell b.End3 + iNHA
F10	Sample source:U251 \| Condition:PUREG4-LA12 \| Method of exposure:Direct exposure
F11	Sample source:U251 \| Condition:PUREG4-LA12 \| Method of exposure:Transwell b.End3
F12	Sample source:U251 \| Condition:PUREG4-LA12 \| Method of exposure:Transwell b.End3 + iNHA
F13	Sample source:U-87MG \| Condition:anti-GLS1 siRNA \| Method of exposure:Transfection
F14	Sample source:U-87MG \| Condition:Control \| Method of exposure:Direct exposure
F15	Sample source:U-87MG \| Condition:Control \| Method of exposure:Transfection
F16	Sample source:U-87MG \| Condition:Control \| Method of exposure:Transwell b.End3
F17	Sample source:U-87MG \| Condition:Control \| Method of exposure:Transwell b.End3 + iNHA
F18	Sample source:U-87MG \| Condition:Lipofectamine \| Method of exposure:Transfection
F19	Sample source:U-87MG \| Condition:PUREG4-LA12-anti-GLS1 siRNA \| Method of exposure:Direct exposure
F20	Sample source:U-87MG \| Condition:PUREG4-LA12-anti-GLS1 siRNA \| Method of exposure:Transwell b.End3
F21	Sample source:U-87MG \| Condition:PUREG4-LA12-anti-GLS1 siRNA \| Method of exposure:Transwell b.End3 + iNHA
F22	Sample source:U-87MG \| Condition:PUREG4-LA12 \| Method of exposure:Direct exposure
F23	Sample source:U-87MG \| Condition:PUREG4-LA12 \| Method of exposure:Transwell b.End3
F24	Sample source:U-87MG \| Condition:PUREG4-LA12 \| Method of exposure:Transwell b.End3 + iNHA

Data matrix